FCS Press Releases

Florida Cancer Specialists & Research Institute, LLC (FCS) has submitted an application to participate in Medicare’s Enhancing Oncology Care Model (EOM), an alternative payment model that aims to address healthcare inequities, reduce costs and improve and report outcomes for cancer patients.

Physicians, clinicians and senior leaders of Florida Cancer Specialists & Research Institute, LLC (FCS) will continue their long history of active involvement with the Florida Society of Clinical Oncology (FLASCO) at the FLASCO Fall Session being held in Orlando, Oct. 28 & 29. 

Florida Cancer Specialists & Research Institute (FCS) pleased to announce that Josh Eaves has been appointed as Chief Development & Strategy Officer, reporting to Chief Executive Officer Nathan H. Walcker.

Michael Diaz, MD, President & Managing Physician of Florida Cancer Specialists & Research Institute, LLC (FCS), will co-chair the Payer Exchange Summit on Oncology Payment Reform presented by the Community Oncology Alliance (COA) on October 24 and 25, 2022 in Tysons Corner, VA.

Senior leaders of Florida Cancer Specialists & Research Institute (FCS) will serve on the faculty for the Association for Value-Based Cancer Care 2022 Summit & Educational Program being held in New York, NY on Oct. 19-21. 

Florida Cancer Specialists & Research Institute, LLC (FCS) welcomes Board-certified medical oncologist/hematologist Judah Friedman, MD to the statewide practice.

Pluvicto ™, the first targeted radioligand therapy approved to treat an advanced prostate cancer.

Operations for Florida Cancer Specialists & Research Institute, LLC (FCS) were halted in all but one medical office last Thursday as Hurricane Ian made its way across Florida. The state-wide practice provides oncology care in nearly 100 locations in the state.

Lucio Gordan, MD, Chief Medical Officer of Therapeutics & Analytics for Florida Cancer Specialists & Research Institute, LLC (FCS), is a featured speaker at the Illumina Genomics Forum being held this week in San Diego.

Florida Cancer Specialists & Research Institute, LLC (FCS) celebrated the groundbreaking for a new cancer center in Wesley Chapel at 30142 State Road 56, Wesley Chapel, Florida 33543.  Scheduled to open in 2024, the facility will replace the current FCS Wesley Chapel location at 26823 Tanic Drive, one of six FCS cancer centers in Pasco County.

Florida Cancer Specialists & Research Institute, LLC (FCS) has been awarded a three-year term of accreditation in radiation oncology, inclusive of each of its nine sites, as the result of a recent review by the American College of Radiology (ACR).

Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce that Board-certified medical oncologist and hematologist Monique Sajjad, DO, a hospitalist with the statewide practice since 2018, is now providing care to patients at the FCS Largo Diagnostic Clinic, located at 1301 2nd Ave. SW, Suite 290, Largo, FL 33770.

Research conducted by Florida Cancer Specialists & Research Institute, LLC (FCS) is among the latest cutting-edge developments and findings in cancer care being presented at the European Society of Medical Oncology (ESMO) Congress being held this week in Paris, France.

A Florida-focused TV commercial that captures the profound nature of a cancer patient’s journey was recognized with top honors among more than 6,500 entries from around the globe in the 2022 Hermes Creative Awards.

Grand Opening of FCS laboratory in Fort Myers, expands the FCS genomic testing capabilities to include Next Generation Sequencing.

Florida Cancer Specialists & Research Institute (FCS) is pleased to welcome new members to its senior management team.